Dysregulation of RGS Proteins by Psychostimulants
Journal: Journal of Addiction & Prevention (Vol.2, No. 1)Publication Date: 2014-06-30
Authors : Rong Chen; Scott E. Hemby;
Page : 01-07
Keywords : RGS Proteins; Dopamine; Dopamine D2 Receptors; Psychostimulant;
Abstract
Regulator of G protein signaling (RGS) proteins are a class of proteins that negatively modulate GPCR-mediated G protein signaling. The distribution of subtypes of RGS proteins is brain region specific. Several subtypes of RGS proteins are present in the mesolimbic dopaminergic pathway and are subjected to modulation by psychostimulants. Acute or chronic exposure to psychostimulants induces changes in mRNA levels of RGS in a subtype-, brain region-, and time-dependent manner. The dynamic changes in the abundance of RGS proteins by psychostimulant treatment may be associated with dopamine receptor sensitization or desensitization, a potential mechanism underlying drug sensitization or tolerance. Small molecule RGS inhibitors are useful tools for studying in vivo function of RGS proteins and are potential therapeutics for the treatment of psychostimulant addiction.
Other Latest Articles
- Specialty Trainees’ Understanding of End-of-Life Care Symptom Management and End-of-Life Care Pathway: A Quantitative and Qualitative Pilot Study
- Does Peer-Delivered Information at Music Events Reduce Ecstasy and Methamphetamine Use at Three Month Follow-Up? Findings from a Quasi-Experiment across Three Study Sites
- Number and Necessity of Tests Performed In the Last Week of Life of a Cancer Patient
- Flexibility in Design, Outcomes and Analysis in “Evidence- Based” Drug Prevention Research: The Case of the Midwestern Prevention Project
- ICHTHYOFAUNA OF WATER BODIES OF THE NATIONAL NATURE PARK “TUZLA LAGOONS” AND ITS COMMERCIAL FISHERIES EXPLOITATION
Last modified: 2015-06-23 16:13:45